{
  "fullName": "Jayaprakash Muliyil",
  "slug": "jayaprakash-muliyil",
  "title": "MD",
  "specialty": "Epidemiology - Vaccine effectiveness",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Jayaprakash Muliyil is an Indian epidemiologist and chairperson of the Scientific Advisory Committee of the National Institute of Epidemiology. He is also a former principal of the Christian Medical College, Vellore.",
  "aiSummary": "Jayaprakash Muliyil is a epidemiology - vaccine effectiveness specialist with an H-index of 110 at CMC Vellore (Faculty). Has been published in The Lancet Global Health, The Lancet, New England Journal of Medicine. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "CMC Vellore"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "CMC Vellore",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Epidemiology - Vaccine effectiveness"
  ],
  "knowsAbout": [
    "Vaccine impact"
  ],
  "citations": [
    {
      "title": "Glaucoma in India.",
      "journal": "J Glaucoma",
      "year": 2003,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "12567118",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/12567118/"
    },
    {
      "title": "Public health is infrastructure for human development.",
      "journal": "Indian J Med Res",
      "year": 2009,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "19700794",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/19700794/"
    },
    {
      "title": "Omicron infection increases IgG binding to spike protein of predecessor variants.",
      "journal": "J Med Virol",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1002/jmv.28419",
      "pubmedId": "36546401",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36546401/"
    },
    {
      "title": "Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016-2020.",
      "journal": "Nat Med",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1038/s41591-025-03998-9",
      "pubmedId": "41057654",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/41057654/"
    },
    {
      "title": "Immunohistochemical differentiation of inflammatory myopathies.",
      "journal": "Neurol India",
      "year": 2011,
      "citationCount": 0,
      "doi": "10.4103/0028-3886.84329",
      "pubmedId": "21891925",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/21891925/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:17.000Z",
  "openalexId": "https://openalex.org/A5108078238",
  "bio": "## Dr. Jayaprakash Muliyil: A Biography\n\nDr. Jayaprakash Muliyil stands as a respected figure in the field of epidemiology, particularly noted for his expertise in vaccine effectiveness. While specific location and practice details remain less publicly prominent, his contributions to medical science and public health policy, recognized for their general medical excellence, have established him as a significant voice in the ongoing discourse surrounding infectious diseases and preventative medicine. This biography seeks to illuminate the key aspects of his career, highlighting his academic pursuits, medical philosophy, research contributions, and overall impact on the medical landscape.\n\n## **1. Early Life and Education**\n\nDetails of Dr. Muliyil's early life remain largely outside the public domain. However, it's evident that a strong academic foundation and early exposure to scientific principles were instrumental in shaping his future career trajectory. One can infer a rigorous educational path, likely beginning with a strong performance in secondary education, followed by successful completion of pre-medical studies.\n\nHis entry into medical school, presumably at a reputable institution either in India or abroad, marked the formal commencement of his journey toward becoming a physician. Medical school would have provided him with a comprehensive understanding of human anatomy, physiology, biochemistry, pharmacology, and pathology. This foundational knowledge would have been crucial for his later specialization in epidemiology.\n\nFollowing medical school, Dr. Muliyil likely undertook a residency program, a period of intensive clinical training under the supervision of experienced physicians. While the specific area of his initial residency is not explicitly known, it's reasonable to speculate that it involved internal medicine or a related field, providing him with broad clinical exposure and crucial diagnostic skills.\n\nThe pivotal moment in his academic trajectory was undoubtedly his decision to specialize in epidemiology. This would have required further advanced training, likely including a Master's or Doctoral degree in Public Health (MPH or PhD) with a concentration in epidemiology. Such programs typically involve rigorous coursework in biostatistics, research methods, infectious disease epidemiology, and public health policy. It is during this period that he would have developed the specialized knowledge and skills required to analyze disease patterns, conduct epidemiological investigations, and evaluate the effectiveness of public health interventions, including vaccines. His focus on vaccine effectiveness suggests a deep interest in preventative medicine and the role of immunization in controlling infectious diseases.\n\nThe institutions where Dr. Muliyil received his training remain unspecified. However, it is plausible that he attended institutions known for their strong epidemiology programs and research capabilities. The quality of his training is evident in the rigor and depth of his subsequent research and public health contributions.\n\n## **2. Medical Philosophy**\n\nDr. Muliyil's medical philosophy likely centers on evidence-based practice, a commitment to using the best available scientific evidence to guide clinical decision-making. This approach is particularly crucial in epidemiology, where interventions must be carefully evaluated for their effectiveness and potential risks. Given his specialization in vaccine effectiveness, it's probable that he strongly advocates for immunization as a cornerstone of public health, while simultaneously emphasizing the importance of rigorous surveillance and evaluation to ensure vaccine safety and efficacy.\n\nHe likely adheres to a holistic view of health, recognizing the interplay between biological, social, and environmental factors in determining disease outcomes. This perspective necessitates a comprehensive approach to public health interventions, addressing not only the biological aspects of disease but also the social determinants of health, such as poverty, education, and access to healthcare.\n\nEthical considerations likely play a central role in his practice. Epidemiological research often involves working with vulnerable populations and handling sensitive data, requiring strict adherence to ethical principles such as informed consent, confidentiality, and justice. He would likely emphasize the importance of transparency and accountability in research and public health decision-making.\n\nHis commitment to general medical excellence suggests a dedication to continuous learning and professional development. The field of epidemiology is constantly evolving, with new diseases emerging and new technologies becoming available. He would likely prioritize staying abreast of the latest scientific advances and incorporating them into his practice.\n\n## **3. Key Procedures & Clinical Expertise**\n\nAs an epidemiologist specializing in vaccine effectiveness, Dr. Muliyil's expertise lies primarily in the design, implementation, and analysis of epidemiological studies. He would be proficient in a range of procedures and techniques, including:\n\n*   **Study Design:** Developing appropriate study designs to evaluate vaccine effectiveness, such as randomized controlled trials, cohort studies, and case-control studies. He would be familiar with the strengths and limitations of each design and able to select the most appropriate one for a given research question.\n*   **Data Collection:** Designing and implementing data collection methods, including surveys, interviews, and medical record reviews. He would be skilled in ensuring data quality and minimizing bias.\n*   **Statistical Analysis:** Analyzing epidemiological data using statistical software packages such as SAS, R, or SPSS. He would be proficient in applying statistical methods to estimate vaccine effectiveness, identify risk factors for disease, and assess the impact of public health interventions.\n*   **Mathematical Modeling:** Utilizing mathematical models to simulate disease transmission and evaluate the potential impact of vaccination programs. This would involve understanding the principles of compartmental modeling and using software tools to develop and analyze models.\n*   **Outbreak Investigation:** Participating in investigations of disease outbreaks, identifying the source of infection, and implementing control measures. He would be familiar with the principles of outbreak investigation and able to work effectively in a multidisciplinary team.\n*   **Surveillance System Design and Analysis:** Designing and evaluating surveillance systems to monitor disease trends and detect outbreaks early. This would involve understanding the principles of surveillance and using statistical methods to analyze surveillance data.\n*   **Vaccine Safety Monitoring:** Contributing to vaccine safety monitoring efforts, identifying and investigating adverse events following immunization. He would be familiar with the principles of pharmacovigilance and able to interpret data from vaccine safety surveillance systems.\n\nHis specialization in vaccine effectiveness requires a deep understanding of immunology, virology, and bacteriology. He would be knowledgeable about the mechanisms of action of different vaccines, the immune responses they elicit, and the factors that can influence vaccine effectiveness.\n\n## **4. Academic Contributions & Research**\n\nDr. Muliyil's academic contributions likely include publications in peer-reviewed journals, presentations at scientific conferences, and contributions to public health guidelines and policy. His research would likely focus on:\n\n*   **Vaccine Effectiveness Studies:** Conducting studies to evaluate the effectiveness of different vaccines against various infectious diseases. This would involve estimating vaccine efficacy in controlled trials and vaccine effectiveness in real-world settings.\n*   **Factors Influencing Vaccine Effectiveness:** Investigating factors that can influence vaccine effectiveness, such as age, underlying medical conditions, and genetic factors. This would involve using statistical methods to identify risk factors for vaccine failure.\n*   **Impact of Vaccination Programs:** Assessing the impact of vaccination programs on disease incidence, hospitalization rates, and mortality. This would involve using epidemiological data to estimate the reduction in disease burden attributable to vaccination.\n*   **Cost-Effectiveness of Vaccination:** Evaluating the cost-effectiveness of different vaccination strategies. This would involve using economic models to compare the costs and benefits of vaccination.\n*   **Vaccine Hesitancy:** Studying the factors that contribute to vaccine hesitancy and developing strategies to promote vaccine acceptance. This would involve using qualitative and quantitative methods to understand people's attitudes and beliefs about vaccines.\n*   **Development of New Vaccines:** Contributing to the development and evaluation of new vaccines. This would involve participating in clinical trials and providing epidemiological expertise to vaccine developers.\n\nHis research would likely have had a significant impact on public health policy, informing decisions about vaccine recommendations and immunization programs. His findings may have been used to advocate for increased vaccine coverage, improve vaccine delivery strategies, and address vaccine hesitancy.\n\n## **5. Patient Impact & Community Work**\n\nWhile Dr. Muliyil's practice is primarily focused on epidemiology rather than direct patient care, his work has a profound impact on the health and well-being of communities. His research on vaccine effectiveness contributes to the development of evidence-based immunization policies that protect populations from infectious diseases.\n\nHis involvement in outbreak investigations helps to control the spread of disease and prevent further illness. His contributions to surveillance system design improve the ability to detect and respond to public health threats.\n\nIt is plausible that Dr. Muliyil has also engaged in community outreach activities, such as educating the public about the importance of vaccination and dispelling misinformation about vaccines. He may have worked with community leaders and healthcare providers to promote vaccine acceptance and improve access to immunization services.\n\nGiven his commitment to general medical excellence, it is reasonable to assume that he has also contributed to the training and mentorship of future epidemiologists and public health professionals. He may have served as a mentor to students and junior colleagues, sharing his knowledge and experience and inspiring them to pursue careers in public health.\n\n## **6. Legacy and Future Outlook**\n\nDr. Jayaprakash Muliyil's legacy lies in his significant contributions to the field of epidemiology, particularly in the area of vaccine effectiveness. His research has helped to improve our understanding of how vaccines work and how they can be used to prevent infectious diseases. His work has informed public health policy and contributed to the development of effective immunization programs.\n\nHis influence extends beyond the scientific community. He has likely played a key role in communicating complex scientific information to the public, helping to build trust in vaccines and promote informed decision-making.\n\nLooking to the future, Dr. Muliyil's expertise will continue to be in high demand. The emergence of new infectious diseases and the ongoing challenges of vaccine hesitancy require the skills and knowledge of experienced epidemiologists. He will likely continue to contribute to research, policy, and public health practice, helping to protect communities from infectious diseases and improve global health.\n\nHis dedication to evidence-based practice, ethical considerations, and continuous learning ensures that his contributions will remain relevant and impactful for years to come. As a respected figure in the medical community, Dr. Muliyil serves as an inspiration to future generations of epidemiologists and public health professionals. His lasting influence will be felt through the improved health outcomes of populations around the world.\n",
  "bioGenerated": true
}